-

FUJIFILM Sonosite Promotes Dennis Giacomino to Chief Commercial Officer

BOTHELL, Wash.--(BUSINESS WIRE)--FUJIFILM Sonosite, Inc., the world leader in point-of-care ultrasound (POCUS) solutions, is pleased to announce that Dennis Giacomino has been promoted to the newly created role of Chief Commercial Officer, effective April 1, 2025, continuing to report to FUJIFILM Sonosite’s President and Chief Executive Officer, Richard Fabian.

Giacomino is a FUJIFILM Sonosite veteran, serving in progressively senior roles in the sales and customer experience function since joining the company in 2009. In his new role, he will assume responsibility for the company’s global commercial business leading sales, sales enablement, and market development of FUJIFILM Sonosite products globally.

"As FUJIFILM Sonosite continues its leadership in the POCUS solutions category, we developed the role of Chief Commercial Officer to ensure long-term growth and success as we continue our global expansion efforts to ensure clinicians around the world have access to FUJIFILM Sonosite ultrasound systems,” said Fabian. "Across his various roles at Fujifilm, Dennis has established a track record of entering new markets, scaling operations, and delivering strong growth performance. We are pleased to have him at the helm of our commercial and customer experience team, consistently delivering the highest level of focus on our customers' success and their ability to provide the best care for their patients.”

“FUJIFILM Sonosite’s commitment to being the most trusted, reliable, and easy to use point-of-care ultrasound partner, coupled with our ambitious long-term growth plans makes the chief commercial officer role a fantastic opportunity,” said Giacomino. “I am thrilled to continue to lead our amazing team that is driven by a passion to help our clinicians solve their problems and execute on the company’s vision to improve patient outcomes and quality of care.”

Dennis is based at FUJIFILM Sonosite’s headquarters in Bothell, Washington.

About FUJIFILM
FUJIFILM Sonosite, Inc. is the innovator and world leader in bedside and point-of-care ultrasound, and an industry leader in ultra-high frequency micro-ultrasound technology. Headquartered near Seattle, the company is represented by a global distribution network in over 100 countries. Sonosite’s portable, compact systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care. For more information, please visit www.sonosite.com.

FUJIFILM Holdings Corporation, headquartered in Tokyo, leverages its depth of knowledge and proprietary core technologies to deliver innovative products and services across the globe through the four key business segments of healthcare, electronics, business innovation, and imaging with over 70,000 employees. Guided and united by our Group Purpose of “giving our world more smiles,” we address social challenges and create a positive impact on society through our products, services, and business operations. Under its medium-term management plan, VISION2030, which ends in FY2030, we aspire to continue our evolution into a company that creates value and smiles for various stakeholders as a collection of global leading businesses and achieve a global revenue of 4 trillion yen. For more information, please visit: www.fujifilmholdings.com.

Contacts

Marissa Confredo
914-343-4761
Marissa.confredo@fujifilm.com

FUJIFILM Sonosite, Inc.


Release Versions

Contacts

Marissa Confredo
914-343-4761
Marissa.confredo@fujifilm.com

Social Media Profiles
More News From FUJIFILM Sonosite, Inc.

FUJIFILM Biotechnologies Named a 2026 CDMO Leadership Award Winner

NEW YORK--(BUSINESS WIRE)--FUJIFILM Biotechnologies, a world-leading contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced therapies, today announced that it has been named a 2026 CDMO Leadership Awards winner in the category of Most Innovative CDMO (Biologics). The CDMO Leadership Awards, presented by Outsourced Pharma and Life Science Connect, are based on direct feedback from biopharma sponsors who have worked with CDMOs over the past 18–24 months....

Fujifilm Announces Availability of FUJINON UA22x4.8BERD 4K Broadcast Zoom Lens

VALHALLA, N.Y.--(BUSINESS WIRE)--FUJIFILM North America Corporation, Optical Devices Division, announces the availability of its new FUJINON UA22x4.8BERD (“UA22x4.8”), a broadcast zoom lens designed for lightweight versatility ideal for a wide variety of production situations. Initial orders of UA22x4.8 are expected to begin shipping to customers by the end of April 2026. UA22x4.8 is a portable zoom lens for 2/3-inch sensor broadcast cameras, covering the wide to telephoto focal range from 4.8m...

Fujifilm Announces Development of FUJINON UA16x4BERD, UA30x7.3BERD, and UA94x8.7BESM 4K Broadcast Zooms

VALHALLA, N.Y.--(BUSINESS WIRE)--FUJIFILM North America Corporation, Optical Devices Division, today announced the development of three new 4K broadcast zoom lenses: FUJINON UA16x4BERD (“UA16x4”), FUJINON UA30x7.3BERD (“UA30x7.3”), and UA94x8.7BESM (“UA94x8.7”). Each of these newly developed lenses covers a wide range of focal lengths in a single unit, providing strong support for immersive storytelling in a variety of broadcast production environments such as sports broadcasts, concerts, live...
Back to Newsroom